Following the launch of the initial findings of the study on 13 November, the full IDF Europe study on Access to Quality Medicines and Medical Devices for Diabetes Care in Europe is now available online.
The first of its kind in the field of diabetes, the study highlights disparities in access to medicines and devices for diabetes care in the 47 countries of the IDF Europe Region. The report aims to provide evidence to policy makers and stakeholders on the current challenges faced by people living with diabetes in terms of access to the treatment they need.
Based on over 1,150 answers to a survey questionnaire, interviews and desk research, the study assesses key dimensions of access (availability, accessibility, affordability, quality and equity) for a range of treatment options used in diabetes care at national level, while offering a comparative, regional perspective that may inspire new solutions based on other countries’ experiences.
Country fact-sheets and sub-regional analysis are available here.